Form 4 for ALLO Allogene Therapeutics, Inc.
Accepted 2021-09-09 00:00:00 ET · period of report 2021-09-09 · accession 0001214659-21-009372 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-09 | 2021-09-09 | ALLO | WITTE OWEN N. | Dir | S - Sale | $25.54 | -5,000 | 221.2K | -2% | -$127.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-09 | S | D | 5,000 | $25.54 | 221,182 | D | — | — |